4Dx,  the latest Australian med-tech company to pass a clinical trial, is eyeing an ASX listing next year. The company has developed a lung imaging platform, XV, that in the words of founder & CEO Andreas Fouras “gives a complete and unprecedented picture of a patient’s lungs”. This can detect diseases such as lung cancer … Continue reading 4Dx’s lung imaging technology just passed a clinical trial. Next step — an ASX listing